ULBI.NASDAQUltralife CORP

8-K: Ultralife Reports Strong Q2 with Record Backlog

Sentiment:

Quarterly Results


Ultralife Corporation announced second quarter results showing a significant improvement in gross profit margin and adjusted EBITDA, alongside a record backlog of $117.5 million.

Better than expectedGross profit margin improved significantly to 28.9% from 23.9% year-over-year, driven by operational efficiencies and favorable product mix.Adjusted EBITDA showed strong growth, increasing by 49.5% to $6.1 million, indicating enhanced operational performance.Record backlog of $117.5 million suggests robust future demand and successful sales pipeline management.GAAP EPS more than doubled, reflecting improved profitability on a per-share basis.

Summary

  • Ultralife Corporation reported second quarter 2026 sales of $47.9 million, a slight decrease of 1.3% from $48.6 million in the prior year's second quarter.
  • Gross profit increased to $13.9 million (28.9% of revenue) from $11.6 million (23.9% of revenue) in Q2 2025, boosted by a $1.1 million IEEPA refund.
  • Operating income rose to $3.4 million from $2.3 million in Q2 2025, despite $0.9 million in one-time costs related to litigation and consulting.
  • GAAP Earnings Per Share (EPS) was $0.15, up from $0.05 in the prior year's second quarter.
  • Adjusted EBITDA reached $6.1 million (12.8% of sales), a substantial increase from $4.1 million (8.5% of sales) in Q2 2025.
  • The company's backlog reached a record $117.5 million at the end of Q2 2026, up from $115.1 million at the end of Q1 2026 and $84.5 million at the end of Q2 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with significant improvements in gross profit margin and adjusted EBITDA, alongside a record backlog, indicating operational progress and strategic execution.

Positives

  • Significant improvement in gross profit margin to 28.9% (26.6% excluding IEEPA refund) from 23.9% in Q2 2025, driven by manufacturing efficiency initiatives and favorable sales mix.
  • Record backlog of $117.5 million, indicating strong future demand and sales pipeline.
  • Adjusted EBITDA increased by 49.5% to $6.1 million, demonstrating improved operational profitability.
  • GAAP EPS more than doubled to $0.15 per share.
  • Communications Systems sales saw a substantial increase of 39.3% year-over-year.
  • Battery & Energy Products gross margin improved to 28.3% from 23.6% due to product mix and the IEEPA refund.

Negatives

  • Overall revenue saw a slight decrease of 1.3% to $47.9 million compared to $48.6 million in Q2 2025.
  • Battery & Energy Products sales decreased by 3.7% year-over-year, primarily due to declines in commercial sales (oil & gas and industrial).
  • Government/defense sales in Battery & Energy Products declined 1.4% due to a large order shipment in the prior year.
  • Operating expenses increased to $10.4 million from $9.3 million, driven by new product development costs and one-time litigation/consulting expenses.

Risks

  • Uncertain global economic conditions, including the impact of tariffs and inflation.
  • Reductions in revenues from key customers.
  • Delays or reductions in U.S. and foreign military spending.
  • Acceptance of new products on a global basis.
  • Disruptions, delays, or material price increases in the supply of raw materials and components due to business conditions, tariffs, global conflicts, or weather.

Future Outlook

The company reinforces its outlook for profitable growth in 2026, citing multi-year revenue opportunities from new product development programs in both Battery & Energy Products and Communications Systems, combined with ongoing gross margin improvement initiatives.

Management Comments

  • "For the second quarter we delivered a 760-basis point improvement in gross profit margin compared to the first quarter, including the contribution of the net IEEPA refund. This improvement reflects measurable benefits realized to date from our initiatives to address manufacturing inefficiencies along with favorable sales mix."
  • "Our Communications Systems business is poised to produce revenue gains as new products move through the capture phase, and continues to expand its opportunity funnel while preparing to launch multiple new products later this year in support of government/defense programs."
  • "At the same time, we are advancing a diverse set of product development programs in our Battery & Energy Products business including programs to support water-based defense drone applications. Several of these programs are expected to transition into production later this year while we continue to execute our backlog."
  • "These multi-year revenue opportunities combined with our ongoing gross margin improvement initiatives, reinforce our outlook for profitable growth in 2026."

Industry Context

StockSavvy.ai notes that Ultralife's focus on defense programs and advanced battery technologies for applications like water-based drones aligns with broader industry trends of increased defense spending and innovation in energy storage solutions.

Legal Proceedings

  • One-time costs of $0.9 million include litigation expenses related to a cyber-insurance claim.

Stakeholder Impact

  • Shareholders: Improved profitability and a record backlog may positively influence investor sentiment and stock performance.
  • Employees: Investment in new product development and manufacturing efficiencies could lead to job security and growth opportunities.
  • Customers: Continued focus on government/defense programs and new product development suggests ongoing support and innovation for key client segments.
  • Suppliers: Increased demand from a record backlog may lead to greater order volumes.

Next Steps

  • Launch multiple new products later this year in support of government/defense programs.
  • Transition several product development programs in Battery & Energy Products into production later this year.
  • Continue to execute on the existing backlog.
  • Hold second quarter earnings conference call on August 7, 2026.

Key Dates

DateDescription
2025-06-30Second quarter ended June 30, 2025
2026-06-30Second quarter ended June 30, 2026
2026-08-07Date of report and press release issuance

Recommendation

hold

While the Q2 results show significant operational improvements and a record backlog, the slight year-over-year revenue decline and ongoing risks related to economic conditions and military spending warrant a cautious approach. The positive trends in profitability and backlog suggest holding the stock to monitor continued execution and growth.

Keywords

Ultralife Corporation, Second Quarter Results, Gross Profit Margin, Adjusted EBITDA, Backlog, Battery Products, Communications Systems, Manufacturing Efficiency

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.